CXCL8 and cancer: Constitutive oncogenic signaling activated through this pathway leads to the production of immunosuppressive cytokines, viz., vascular endothelial growth factor (VEGF) and interleukin 8 (IL-8), which inhibit T cell recruitment to the cancer tissue as well as their activity [52].